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Abstract Tuberculosis (TB) remains as one of the
deadliest diseases after HIV globally with 95 % of deaths
confined to low-and-middle income countries. Pakistan is
fifth among the 22 high-burden TB countries with the
incidence rate of 230/100,000 persons, however, studies
related to prevalent Mycobacterium tuberculosis strains
and their spread, drug resistance pattern and evolutionary
genetics are inadequate. The present study was undertaken
to highlight the circulation of M. tuberculosis strains
causing drug resistant TB in our community by targeting
the molecular marker IS6110 and then characterization of
these strains as Beijing and Non-Beijing genotypes. Spu-
tum samples from 102 MDR TB suspects from different
cities of Punjab were collected and their record was stored
in a database. Sputum samples were evaluated by Ziehl
Neelson staining and cultured on Lownstein Jensen med-
ium by Modified Petroff’s method. DST was performed for
first-line anti-mycobacterial drugs by indirect proportion
method. Mycobacterium tuberculosis isolates were inves-
tigated for the presence of IS6110 and further identification
as Beijing, Non-Beijing or mixed genotype. Percentage of
male and female patients was found to be 58.8 and 41.2 %
respectively. DST showed resistance of 93 % of isolates to
isoniazid and rifampicin. All of the isolates showed posi-
tive results for IS6110 amplification. Based on PCR
amplification of Beijing and non-Beijing primer sets 4.9 %
of the patients showed infection with pure Beijing isolates,
14.7 % with both Beijing and non-Beijing isolates and
80.3 % with pure non-Beijing isolates. Analysis of IS6110
and Beijing sequences showed the presence of putative
transposase conserved domain while non-Beijing sequen-
ces were epitomized with RAMP_I_III superfamily domain
(CRISPR-associated protein family). TB in Pakistan is
predominantly caused by Non-Beijing genotypes, but
Beijing strains showed incessant circulation in our com-
munity as both single and mixed (co-infecting Non-Beijing
and Beijing) strains.
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Introduction
Tuberculosis (TB) continues as one of the deadliest con-
tagious diseases across the globe. Nearly 9 million people
developed TB in 2013 and the year ended with the demise
of 1.5 million people due to TB. Of the total TB cases and
deaths, around 56.25 % are men but the burden of the
disease is eminent in women as well. To no surprise, out of
the total TB cases occurred in 2014, 58 % belonged to the
South-east Asian and Western Pacific regions (WHO
2015).
Pakistan stands fifth among the 22 high-burden coun-
tries and fourth among 27 MDR-TB countries. Nearly
420,000 cases occur each year out of 9000 cases are of DR-
TB. Socio-economic conditions are greatly influenced by
TB as 75 % of cases are among the dynamic (15–45) age
group (Programme NTC 2012). TB is closely associated to
poverty and social deprivation (Lo¨nnroth et al. 2009). Poor
living conditions like overcrowding, poor ventilation, close
proximity and malnutrition are the major risk factors for
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contracting TB infection and disease. Lack of awareness to
TB epidemiology, management and control in TB endemic
areas worsens the situation (Narasimhan et al. 2013).
Furthermore, the rapid increase in the incidence of
MDR-and XDR-TB complicated the issue. MDR, resis-
tance to at least 2 most potent first line drugs (rifampicin
and isoniazid) while extensive drug resistant tuberculosis
(XDR-TB) is defined as MTB strains resistant to first line
drugs and also resistant to any fluoroquinolone and at least
one of the three second line injectable drugs: kanamycin
(KAN), amikacin (AMK), and capreomycin (CAP)
(Hamilton et al. 2007).
The timely and accurate diagnosis of drug resistant TB
is utmost important for suitable intervention to halt the
disease progression. It also facilitates to halt the trans-
mission of MDR and XDR-TB strains (Lange et al. 2014).
Drug susceptibility testing of MTB contains two folds
importance. One patient infected with resistant bacilli can
achieve a favorable response after DST results if treatment
is adjusted after his DST pattern. Secondly DST results will
be useful to monitor the National TB control programs
efforts (Thomsen et al. 2000). Although the traditional
DST has high sensitivity and specificity, it is time-con-
suming (6–9 weeks) which demands for rapid drug resis-
tance detection assays.
Molecular diagnostic tools have provided the solution to
this problem. Nucleic acid amplification tests (NAATs) are
based on the identification and amplification of nucleic
acids’ sequences that are highly specific to Mycobacterium
tuberculosis (Drobniewski et al. 2012).
Insertion sequences are small mobile elements which are
proved to be present in various bacterial genomes. IS6110
is one of the IS elements which are intensively studied and
reported to be specific to M. tuberculosis complex genome.
IS6110 is present in multiple copies within the M. tuber-
culosis genome which makes it an important epidemio-
logical tool for strain identification (Mene´ndez et al. 2014;
Siddiqui et al. 2013). The capacity to differentiate between
the strains depends on the variation in copy number as well
as the insertion sites of IS6110 (Thorne et al. 2011).
Molecular epidemiological studies of tuberculosis are
worthwhile in understanding the transmission and geo-
graphical pattern of drug resistant strains. Such studies
have discovered multiple mycobacterial lineages world-
wide (Filliol et al. 2002). Drug resistance patterns shown
by genotypes of M. tuberculosis vary globally. Resistance
pattern showed by Beijing genotype is different region-
wise (Glynn et al. 2002); however, this genotype has been
largely reported to be related to DR-TB outbreaks in
Africa, Asia and Europe (Johnson et al. 2010; Niemann
et al. 2010). Beijing genotype has been shown to be
associated with MDR-TB incidence in Pakistan (Tanveer
et al. 2008).
Infection and recurrence of TB have been believed to be
caused by primary infection or reactivation of single strain
for decades (Zheng et al. 2015). However, research in the
field ofmolecular epidemiology has revealed the termmixed
infection of multiple strains among single individuals and
has got prime importance among researchers and TBControl
programs (Zetola et al. 2014). Mixed Infection can enhance
the ability of MTB strains to acquire additional mutations
and increase the rate of treatment failure (Cohen et al. 2012).
By amplifying and detecting the DNA sequences of
Beijing and Non-Beijing strains, it has been observed that
many retreatment cases contain multiple strains. It has been
extensively studied that the region Rv2819 and part of
Rv2820 inM. tuberculosis genome is specifically deleted in
all Beijing strains, while it is present in Non-Beijing strains
(Khosravi et al. 2014).
As mixed infection may be particularly common in high
burden drug resistant TB countries, so the aim of the pre-
sent study was to elucidate the drug resistant pattern of
multi-drug resistant MTB strains in our community,
genotypic identification and detection of mixed infection of
Beijing and non-Beijing strains in Pakistan and its preva-
lence in new and retreatment cases on the basis of deleted
and intact genetic regions in Beijing and Non-Beijing
strains of M. tuberculosis respectively.
Materials and methods
Patients and specimens
Sputum samples of 102 patients suspected of MDR-TB
were collected from different PMDT (Programmatic
Management of Drug resistant TB) sites during a period of
5 months (August 2014 to December 2014). After taking
informed consents, a single Sputum sample from each
patient was collected according to the guidelines provided
by WHO.
Sample processing and culturing
For preliminary detection of MTB Isolates, all sputum
samples were inoculated on Lowenstein Jensen medium
after being digested and decontaminated by Modified
Petroff’s method using 4 % NaOH solution and then con-
centrated by centrifugation at 3000g for 30 min (Kent and
Kubica 1985; Tripathi et al. 2014). Concentrated samples
were then used for smearing and culturing (Cappuccino
and Sherman 2014).
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Smear microscopy
Each sample was used for smearing and then checked for
the presence of acid fast bacillus by Ziehl Neelson staining
(Cappuccino and Sherman 2014).
Drug susceptibility testing
Standard drug susceptibility testing (DST) of first line
drugs using 1 % indirect proportion method on solid
Lowenstein–Jensen medium (Canetti et al. 1969) was
performed on positive cultures only. H37Rv strain was
used as control. DST was conducted using LJ medium
infused with isoniazid (Inh), rifampin (Rif), ethambutol
(Emb), and streptomycin (Stm). The antibiotic concentra-
tions in the medium were 20 lg/ml for Inh, 40 lg/ml for
Rif, 2 lg/ml for Emb, and 10 lg/ml for Stm.
Genomic DNA isolation and gel electrophoresis
Genomic DNA of drug resistant MTB strains was extracted
by the CTAB method (Amaro et al. 2008). A loopful of
mycobacterial culture from LJ slope was taken and trans-
ferred to eppendorfs containing low T.E buffer. Inactivate
the mycobacterial cells by heating at 80 C for 1 h. After
cooling to room temperature, bacterial suspension cultures
were incubated overnight at 37 C with lysozyme then
incubated them with SDS and Proteinase K at 65 C for
20 min following incubation with pre-warmed CTAB/
NaCl solution at same temperature for 10 min. Finally, the
DNA was precipitated by using phenol–chloroform solu-
tion and purified by using ethanol. DNA isolation was
confirmed by visualizing the bands on 0.9 % agarose gel.
PCR for the detection of IS6110
The presence of IS6110 specific for M. tuberculosis in all
isolates was tested by using primer set ISF 50CCTGCGAG
CGTAGGCGTCGG30 and ISR 50CTCGTCCAGCGCCG
CTTCGG 30. PCR amplicon obtained by using same pri-
mers from DNA isolated from H37Rv standard strain was
used as positive control whereas for the negative control
PCR reaction mixture without any DNA was used.
PCR for the detection of Beijing and Non-Beijing
strains
As previously mentioned that region spanning genes
Rv2816 to Rv2819 and part of Rv2820 is missing in all
Beijing strains so for detection of Beijing strains primer set
BF 50ACCGAGCTGATCAAACCCG 30 and BR 50 ATG
GCACGGCCGACCTGAATGAACC 30 for amplification
of 239-bp fragment containing region specific part of
Rv2819 and part of Rv 2820 was used. While for the
detection of Non-Beijing strains, amplification of 539-bp
PCR fragment was amplified using primer set 50GATCGC
TTGTTCTCAGTGCAG30and NonBR 50CGAAGGAGTA
CCACGTGGAG 30 containing region specific for Rv2819.
PCR product purification, sequencing
and bioinformatics
PCR products were purified by using GeneJETTM Purifi-
cation kit (#K0701). PCR products were sequenced by
Sanger sequencing method from AB sequencer (Applied
Bioscience). Sequencing results were analyzed using the





A total of 102 suspected MDR-TB samples were collected
from 6 big cities of Punjab Province. Samples were
obtained from both males and female patients with mean
age of 33.3 years. Proportion of male and female patients
was 58.8 % (mean age 33.3) and 41.2 % (mean age 33.2),
respectively. Incidence of Drug resistant TB in our study
group was found to be higher in age group of 30–35 years.
Samples included in the study group were divided into two
major subsets, that is, new and retreatment cases (Persons
who default from the initial treatment and fail to improve,
or relapse after the initial treatment Becerra et al. 2000) on
the basis of their treatment status.
Drug-susceptibility pattern
Out of the total 102 isolates, 95 (93 %) showed resistance
to isoniazid and rifampicin and considered as MDR.
Among 95 MDR samples, 44 were new cases and 51 were
retreatment cases Resistance to streptomycin was found to
be greater than ethambutol. 51 % of the isolates showed
resistance to all four first-line drugs (Table 1).
PCR amplification of IS6110
PCR amplification using primers targeting IS6110 showed
positive amplification with 100 % of the total (102) isolates
(Fig. 2).
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PCR based detection of Beijing and Non-Beijing
strains
Among 102 collected isolates 4.9 % of the isolates showed
positive amplification with the primer set targeting Beijing-
specific sequence while for non-Beijing amplification
showed positive for 80.3 % of the isolates. Mixed infection
with both Beijing and Non-Beijing strain has also been
detected in 14.7 % of the patients (Fig. 1) as the DNA
isolated from their cultures showed positive amplification
with Beijing and non-Beijing primer sets (Fig. 2).
Analysis of new and retreatment cases showed that non-
Beijing strains contribute the largest proportion of our
isolates (Table 2).
Sequence analysis
BLAST results based on IS6110 showed 100 % sequence
similarity with putative transposases of M. tuberculosis
isolates. Analysis of Beijing sequences with NCBI BLAST
showed 98 % sequence similarity with transposase of M.
tuberculosis Beijing-like strain (GenBank: CP010873.1)
while non-Beijing sequences showed 99 % sequence sim-
ilarity with CRISPR-associated protein Csm5 of M.
tuberculosis. 3 of the non-Beijing sequences have been
submitted to the Genbank and their accession numbers are
KR362602 (Non-Beijing 55), KR362601 (Non-Beijing 65)
and KR362600 (Non-Beijing 69). Phylogenetic analysis
revealed similarity with reference strains as well as among
the strains themselves (Figs. 3, 4, 5).
Discussion
Acid-fast bacilli (AFB) microscopy and mycobacterial
culturing have been practiced for years for the lab diag-
nosis of M. tuberculosis. But, being labour intensive and
time consuming, these methods demand for rapid, more
efficient and reliable methods for TB diagnosis. Timely
and accurate diagnosis is crucial to the commencement of
effective antimycobacterial therapy of TB cases. PCR is
greatly used for the detection of M. tuberculosis either
using sputum or the cultures obtained from sputum
(Huang et al. 2010; Kaul 2001; Soini and Musser 2001).In
case of smear positive pulmonary TB, diagnosis is con-
firmed or dismissed in just 48 h using PCR rather than
2–8 weeks for culturing (Balamurugan et al. 2006).
Newer molecular methodologies have identified extensive
genetic diversity among M. tuberculosis isolates thereby
making it quite difficult to classify different disease
causing strains precisely (Van Embden et al. 1993). In the
present study, PCR amplification targeting genetic
markers specific to distinct evolutionary lineages was
utilized to differentiate M. tuberculosis isolates on the
basis of presence or absence of these markers. This
method provided us with a simplified approach to estimate
the prevalence of Beijing and Non-Beijing strains of M.
tuberculosis in our community.
Our results showed that overall drug resistance is higher
in retreatment cases. Complete resistance to both isoniazid
and rifampicin in 93 % of the samples confirmed the iso-
lates as MDR. In addition, resistance to other FLDs was
found to be significant among both new and retreatment
cases.
IS6110 is considered as ideal target in epidemiological
studies of M. tuberculosis because it is randomly dis-
tributed and present in multiple copies in the MTB
Table 1 Percentage of resistance to FLDs among new and retreatment cases
First-line drug(s) No. (%) of new cases resistant
to the drug(s) (n = 51)
No. (%) of retreatment cases resistant
to the drug(s) (n = 51)
Total no. (%) of
cases (n = 102)
Inh 47 (92 %) 51 (100 %) 98 (96 %)
Rif 47 (92 %) 51 (100 %) 98 (96 %)
Inh, Rif 44 (86.2 %) 51 (100 %) 95 (93 %)
Inh, Rif, Emb 22 (43.14 %) 38 (74.5 %) 60 (58.8 %)
Inh, Rif, Stm 26 (50.98 %) 41 (80.4 %) 67 (65.6 %)








Fig. 1 Magnitude of different genotypes of M. tuberculosis among
the study isolates
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Fig. 3 Comparison of genetic clusters on the basis of translated
protein sequences. a Aligned IS6110sequences: cluster 1 (46, 2, 6) is
indicated with blue arrows; cluster 2 (69, 56, 9) is indicated with red
arrows. b *Phylogram of the M. tuberculosis sequences on the basis
of IS6110. *The evolutionary history was inferred using the
Neighbor-Joining method. The optimal tree with the sum of
branchlength = 3.79170867 is shown. The percentage of replicate
trees in which the associated taxa clustered together inthe bootstrap
test (100 replicates) are shown next to the branches. The tree is drawn
to scale, with branch lengthsin the same units as those of the
evolutionary distances used to infer the phylogenetic tree. The
evolutionarydistances were computed using the p-distance method
and are in the units of the number of base differences persite. The
analysis involved 19 nucleotide sequences. All positions containing
gaps and missing data were eliminated. There were a total of 62
positions in the final dataset. Evolutionary analyses were conducted in
MEGA6
Fig. 2 Division of polymerase chain reaction (PCR) amplified
products. a PCR amplification with primer set 1 (ISF and ISR;
Product size*124 bp). b PCR amplification with primer set 2 (NB-F
and NB-R; Product size 569 bp). c PCR amplification with primer set
3 (BF and BR; Product size 239 bp). L: 100 bp molecular marker;
Arabic numerals: clinical samples; NC: negative control (in this case
ddH2O)
Table 2 Frequency of different
types of infections among new
and retreatment MDR cases
Type of infection No. (%) of new
cases (n = 44)
No. (%) of retreatment
cases (n = 51)
Total no. (%) of
cases (n = 95)
Beijing 3 (6.8 %) 2 (3.9 %) 5 (5.3 %)
Non-Beijing 29 (65.9 %) 46 (90.2 %) 75 (78.9 %)
Mixed 12 (27.2 %) 3 (5.9 %) 15 (15.7 %)
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genome. Many studies claimed the usefulness of PCR
based techniques in identification of MTB using
IS6110 as a target (Doroudchi et al. 2000; Siddiqui
et al. 2013), and our study confirmed these results by
showing high degree of sensitivity of PCR based
detection of MTB.
In our study results, most strains belong to the non-
Beijing family i.e. 70.6 % of the new and 90.2 % of the
retreatment cases. The higher percentage of non-Beijing
strains was found in accordance with another study carried
out in Pakistan suggesting the higher prevalence of Central
Asian strain (CAS1) family of M. tuberculosis rather than
Beijing genotype (Hasan et al. 2006). Another study from
Punjab (Pakistan) showed that non-Beijing isolates (91.1 %
of the total isolates) are more prevalent than Beijing iso-
lates (8.9 %) in the region (Arif and Hussain 2014). Fur-
thermore, mixed infection with Beijing and non-Beijing
strains constitutes the second highest proportion in our
study. However, the percentage of mixed infection was
found to be higher in new cases as compared to retreatment
cases. The existence of mixed infection in *23 % of the
new cases may suggest that reinfection is common in a
high burden country like Pakistan. A speculation can be
made that a continuing TB infection in an individual with
one strain may weaken the immune response thus
increasing the risk of super infection with a different strain
before advancing to a single disease episode. Another
proposition is that the super infection after some time of the
primary infection may trigger the disease development and
activation of the initial infection. Previous reports proposed
that a significant portion of first episodes of disease is the
probable result of reinfection which depends on indigenous
disease prevalence and extent of protection given by an
earlier infection (Cohen et al. 2007, 2012; Du Plessis et al.
2001; Wang et al. 2015). Although the percentage of



















Fig. 4 Comparison of genetic clusters on the basis of translated
protein sequences. a Aligned Beijingsequences: cluster 1 (Beijing 7)
is indicated with blue arrows; cluster 2 (Beijing 1211, 36) is indicated
with redarrows; cluster 3 (Beijing 33) is indicated with orange
arrows. b *Phylogram of theM. tuberculosis sequences onthe basis of
Beijing-specific sequences. *The evolutionary history was inferred
using the Neighbor-Joining method. The optimal tree with the sum of
branchlength = 2.46910112 is shown. The percentage of replicate
trees in which the associated taxa clustered together inthe bootstrap
test (100 replicates) are shown next to the branches. The tree is drawn
to scale, with branch lengths inthe same units as those of the
evolutionary distances used to infer the phylogenetic tree. The
evolutionary distanceswere computed using the p-distance method
and are in the units of the number of base differences per site. The
analysis involved 10 nucleotide sequences. Codon positions included
were 1st ? 2nd ? 3rd ? Noncoding. All positionscontaining gaps
and missing data were eliminated. There were a total of 178 positions
in the final dataset. Evolutionary analyses were conducted in MEGA6
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Beijing strains, but their higher frequency among new
cases as both single infecting strain or causing mixed
infection with other strains may suggest that they are
continually circulating and evolving in our environment.
Molecular diagnostic tools are vital to identify and char-
acterize drug-resistant M. tuberculosis strains. In a high-
burden and low-resource setting, like Pakistan PCR-based
approaches provide rapid diagnosis of drug-resistant TB
and insights on the prevalent MTB genotypes in the region.
Non-Beijing strains are mostly prevalent in this region but
continual circulation of Beijing strains has also been indi-
cated. Furthermore, in silico methods aid in precise
characterization of these strains by nucleotide and amino
acid sequence analysis.
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Fig. 5 Comparison of genetic clusters on the basis of translated
protein sequences. a Aligned Non-Beijingsequences cluster 1 (Non-
Beijing 203, 58, 56, 12) is indicated with blue arrows; cluster 2 (Non-
Beijing 6, 55) isindicated with red arrows; cluster 3 (Non-Beijing
182, 65, 69, 48) is indicated with orange arrows. b *Phylogram ofthe
M. tuberculosis sequences on the basis of non-Beijing specific
sequences. *The evolutionary history was inferred using the Neigh-
bor-Joining method. The optimal tree with the sum of branch length =
4.40932938 is shown. The percentage of replicate trees in which the
associated taxa clustered together inthe bootstrap test (100 replicates)
are shown next to the branches. The tree is drawn to scale, with
branch lengths in the same units as those of the evolutionary distances
used to infer the phylogenetic tree. The evolutionary distances were
computed using the p-distance method and are in the units of the
number of base differences per site. The analysis involved 14
nucleotide sequences. Codon positions included were
1st ? 2nd ? 3rd ? Noncoding. All positions containing gaps and
missing data were eliminated. There were a total of 137 positions in
the final dataset. Evolutionary analyses were conducted in MEGA6
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